Becton Seeks New Trial, Nix Of $114M Antitrust Verdict

Law360, Washington (October 15, 2013, 2:44 PM EDT) -- Becton Dickinson & Co. urged a Texas federal judge Friday to nix a $113.5 million damages verdict in favor of longtime patent litigation rival Retractable Technologies Inc. and send the syringe market monopolization case back to a jury for a new trial, claiming the company couldn't prove Becton Dickinson's alleged actions led to decreased competition.

Although a jury determined in September that Becton Dickinson tried to monopolize the safety syringe market with false advertising practices, leading to the $113.5 million award for antitrust damages for deception, the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.